Acerca de StandardX
StandardX desarrolla una plataforma compacta de aceleradores de partículas de alta potencia, diseñada para producir varios isótopos a partir de una instalación estandarizada. Fundada en 2025, se centra inicialmente en el suministro de isótopos para el diagnóstico y tratamiento del cáncer, la investigación y los futuros sistemas de fusión.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.